MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 145 filers reported holding MACROGENICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,722 | -77.9% | 14,318 | -66.1% | 0.00% | – |
| Q1 2023 | $302,495 | +45.5% | 42,189 | +36.2% | 0.00% | – |
| Q4 2022 | $207,862 | +2.4% | 30,978 | -55.1% | 0.00% | – |
| Q2 2022 | $203,000 | -72.8% | 68,996 | +48.4% | 0.00% | – |
| Q4 2021 | $746,000 | -17.4% | 46,495 | +7.7% | 0.00% | – |
| Q3 2021 | $903,000 | -36.8% | 43,157 | -18.9% | 0.00% | – |
| Q2 2021 | $1,428,000 | -48.2% | 53,225 | -38.5% | 0.00% | – |
| Q1 2021 | $2,756,000 | +159.3% | 86,529 | +86.0% | 0.00% | – |
| Q4 2020 | $1,063,000 | +2.2% | 46,516 | +12.7% | 0.00% | – |
| Q3 2020 | $1,040,000 | +55.9% | 41,287 | +72.9% | 0.00% | – |
| Q2 2020 | $667,000 | +350.7% | 23,879 | +76.1% | 0.00% | – |
| Q4 2019 | $148,000 | +13.8% | 13,557 | +33.6% | 0.00% | – |
| Q3 2019 | $130,000 | -68.3% | 10,151 | -55.5% | 0.00% | -100.0% |
| Q1 2019 | $410,000 | +0.7% | 22,787 | +41.0% | 0.00% | 0.0% |
| Q1 2018 | $407,000 | +46.9% | 16,157 | +26.7% | 0.00% | -75.0% |
| Q2 2014 | $277,000 | – | 12,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |